Axsome Therapeutics (NASDAQ:AXSM) Upgraded to Hold at StockNews.com

Axsome Therapeutics (NASDAQ:AXSM – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday. AXSM has been the topic of a number of other reports. HC Wainwright reaffirmed a “buy” rating and issued a $200.00 price target on shares of […]

Related Keywords

China ,United States ,America , ,Axsome Therapeutics Inc ,Nasdaq ,Tower Research Capital ,Quent Capital ,Morgan Stanley ,China Universal Asset Management Co ,Armstrong Advisory Group Inc ,Axsome Therapeutics ,Get Rating ,Financial Advisors ,Advisory Group ,Universal Asset Management ,Research Capital ,Products Overview ,Pipeline Overview ,Axsome Therapeutics Daily ,Nasdaq Axsm ,Axsm ,Medical ,Upgrade ,Stocknews Com ,